SDC2 and acute respiratory distress syndrome: CD362+ UC-hMSC therapy administered at 6 h + 12 h was similar to that at delivered at 0 h, with both equally effective in attenuating the E. coli-induced ARDS, while one dose of hMSC therapy at 6 h time point was ineffective.